BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)
$1.3 0.6399 (96.9399%)
Analysed BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
25-08-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
11-09-2026
yahoo.com
BDRX: Expanding Phase 3 SERENTA Trial into Canada; 73 Patients Enrolled Thus Far
29-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
02-09-2026
yahoo.com
Postponement and Re-scheduling of Annual General Meeting
17-06-2026
yahoo.com
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
29-06-2026
yahoo.com
Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants
30-06-2026
yahoo.com
Result of Annual General Meeting
30-06-2026
yahoo.com
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
19-08-2026
yahoo.com
Interim results for the six months ended June 30, 2026
11-09-2026
yahoo.com
What is the current price of BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)?
The current price of BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) is $1.3.
BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) since the previous trading day is $0.6399.
BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) since the previous trading day is 96.9399%.
What is the most recent average sentiment score for BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)?
The most recent average sentiment score for BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)?
The most recent sentiment for BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) is .
SEC-8K** Filing Available For BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.